Cargando…
凡德他尼治疗非小细胞肺癌的meta分析
BACKGROUND AND OBJECTIVE: Vandetanib is a small molecule inhibitor against vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR). The aim of this study is to evaluate the efficacy and safety of vandetanib as a second-line treatment for advanced non-small cel...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999870/ https://www.ncbi.nlm.nih.gov/pubmed/22429581 http://dx.doi.org/10.3779/j.issn.1009-3419.2012.03.07 |